不同的儿科药物对RMGIC的影响:一项比较研究
Ahtesham A Qurishi1, Mohammed S Al Dira2, Amal H Sholan3
1Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, Jizan University, Jazan, Saudi Arabia.
Journal of pharmacy & bioallied sciences
|February 10, 2025
概括
儿科药物可能会损害在牙科中使用的树脂修饰玻璃离子体水泥 (RMGIC). 抗咳糖显著降低RMGIC微硬度,增加表面粗度,影响牙修复的耐用性.
科学领域:
- 牙科材料科学 牙科材料科学
- 儿科牙科 儿科牙科
- 生物材料 相互作用 相互作用
背景情况:
- 树脂修饰玻璃离子体水泥 (RMGIC) 是儿童牙科中常见的牙科修复材料.
- 经常使用的儿科药物和RMGIC之间的相互作用尚不清楚.
- 药物对RMGIC的潜在降解可能会危及牙修复的寿命.
研究的目的:
- 评估常见儿科药物对RMGIC物理性质的影响.
- 确定哪些类型的儿科药物对RMGIC构成最大风险.
- 为儿童修复牙科的材料选择和临床实践提供见解.
主要方法:
- 准备了60个RMGIC标本,并分为五组.
- 群体被浸泡在抗生素糖,抗发烧糖,维生素糖,抗咳糖或蒸水 (控制) 中长达14天.
- 浸泡前后测量了微硬度和表面粗度,并使用ANOVA和Tukey测试进行了统计分析.
主要成果:
- 所有测试的儿科药物都显著改变了RMGIC属性.
- 抗咳糖显示出最明显的负面影响,微硬度降低了高达18.40%,表面粗度增加了高达21.40%.
- 对照组 (蒸水) 没有显著变化,表明药物诱导的影响.
结论:
- 常见的儿科药物,特别是酸性配方,如抗咳糖,可能会损害RMGIC的耐用性.
- 这些发现突出了进一步研究开发更耐药的牙科材料或为儿科修复提供保护策略的需要.
- 临床医生应考虑液体药物对儿童RMGIC恢复寿命的潜在影响.
相关概念视频
Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


